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20:4n-6) and EPA are involved in the production and
modulation of eicosanoids respectively. DHA is a vital
component of the phospholipids of cellular
membranes, especially in the brain and retina, and
necessary for their proper functioning. An imbalance
in n-3/n-6 ratio can accentuate n-3 fatty acid
deficiency state, as shown by earlier studies. The
ratio is found to have increased in industrialized
societies because of increased consumption of
vegetable oils rich in n-6 fatty acids, ie, linoleic acid
(18:2n-6) and reduced consumption of foods rich in
n-3 fatty acids. Another important feature of n-3 fatty
acids is their role in the prevention and modulation
of certain diseases that are common. A partial list of
diseases that may be prevented or ameliorated with
n-3 fatty acids is given below.
z Coronary heart disease and stroke
z Diabetes
z Cancers of the breast, colon, and prostate
z Hypertension
The LC - PUFAs are also recognized to have
beneficial therapeutic, physiological and nutritional
effects on human health.
Imported products (PUFA supplement) include
Seven Seas by a UK healthcare company producing
PUFA rich Cod Liver Oil by Ocean Gold™ technology. A
value-added PUFA concentrate named “fish oil-1000
natural omega 3®” containing 100 capsules
manufactured by Healtheries of New Zealand Ltd.
priced  at about ` 1150 per pack, is currently being
marketed in India by Perma Healthcare, Bangalore.
“EPAX 1050 TG®”, a marine omega 3 formula
produced from selected marine oils and marketed by
EPAXAS, Norway is an imported product containing
Dietary fats are used to build every cell in the
body and cell membranes are made of a variety of
individual fatty acids which are carboxylic acids with
long hydrocarbon chains (usually C12-22). The
essential fatty acids from marine fish have protective
mechanisms against coronary heart disease, which
became apparent in the investigations of the health
status of Greenland Eskimos who consumed diets very
high in fat from seals,whales, fish etc, and yet had a
low rate of coronary heart disease. This paradox was
explained by the fact that the Eskimos diet contained
large quantities of the very-long-chain and highly
polyunsaturated fatty acids with C20-22 carbons and 5-
6 olefinic bonds, which are abundant in marine fish,
but scarce or absent in terrestrial animals and plants.
Fatty acids with two or more double bonds are termed
as polyunsaturated fatty acids (PUFAs) which are
broadly divided into two major families, n-3 and n-6
PUFAs. The long chain C20-22 n-3 fatty acids are found
abundantly  in marine  fish and phytoplankton. These
affect many physiological processes including
cognitive function, visual acuity, immunosuppressive
and anti-thrombic activities along with a major role
in glucose and lipid metabolism. Research on
exploring sources for long-chain C20-22 PUFAs (LC-
PUFAs) such as Eicosapentaenoic acid (EPA, 20:5
n-3) and Docosahexaenoic acid (DHA, 22:6n-3) for
nutrition have received considerable attention (Fig.
1). Since these PUFAs are usually low in abundance
in humans, but  regarded as essential they have to
be supplied in the diet. The importance of PUFAs in
human nutrition has been extensively investigated
during the past 20 years. DHA one of the important
PUFAs maintains structural and functional integrity
in larval cell membranes in addition to the neural
development and function, while Arachidonic acid (AA,
Mar. Fish. Infor. Serv., T & E Ser., No. 223 & 224, 20154
17% EPA for use as fish feed supplement. OMEGA XL®
is marketed by DeColores in a bottle containing 60
capsules of refined combination of omega-3’s costing
about $50 per pack, as a nutraceutical. Great Health
Works manufactures a concentrate of PUFA from Blue
Grenadier Fish that is also a costly PUFA supplement.
DSM Nutritional Products, Switzerland manufactures
and sells PUFA concentrate under the trade name
ROPUFA® produced from refined vegetable and
marine oils. These products are currently imported
to meet the domestic demand of PUFA concentrate
formulation for fish feed supplements and
nutraceutical purposes. This underlied the need to
develop an indigenous n-3 (PUFA) supplement for
which the Marine Bioprospecting section of Marine
Biotechnology Division screened locally available low-
value fish for n-3 PUFAs, concentrating these
essential fatty acids therefrom by chemical and/or
enzymatic process.The aim was to develop an
indigenous n-3 PUFA enriched formulation(s)
comprising fatty acid concentrate and individual or
combination of additives with potential antioxidant
properties to form a stabilized and concentrated form
of long chained n-3 PUFAs which may be a cheaper
alternative to the imported PUFA supplements, and
will be useful as nutraceuticals and in mariculture
operations for fish larval nutrition.
 It is believed that the optimal formulations for
the first-feeding fish larvae should simulate the yolk
composition and to some extent reflect the nutrient
requirements and metabolic capacities of the pre-
feeding fish. Dietary long chain PUFAs play an
important role as vital sources of essential fatty
acids, needed for normal growth and suvival. Larvae
of many marine fishes require highly unsaturated
fatty acids of the n-3 series, such as, DHA due to the
absence of essential enzymes required for
biosynthesis of C20-22 LC-PUFAs from their short chain
analogues (Fig. 2). Some investigations have shown
that DHA is superior to EPA for larval fish suggesting
a different physiological function.
The important natural sources of n-3 LC-PUFAs
are fishes such as mackerel, sardines, sharks;
microalgae, polychaetes, etc. Among these, sardines
are inexpensively available and contain considerable
amount of PUFAs, particularly 20:5n-3. Hence sardine
oil was preferred as the raw material to formulate
Fig. 1.  C20-22 polyunsaturated fatty acids (Eicosapentaenoic and Docosahexaenoic acids)
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the n-3 C20-22 LC- PUFA concentrates based on different
physicochemical properties associated with the
olefinic bonds in fatty acids and/or acyl chain length.
The objective was to purify EPA and DHA from sardine
oil by saponification of fish oil to derive free fatty
acids, enrichment of PUFA content from the mixed
fatty acid concentrate by amide fractionation and
chromatography by utilizing the silica gel complexed
with a d-block element.The unique substrate
specificity of microbial triacylglycerol acyl hydrolases
was utilized for the enhancement of PUFA content in
triglycerides to further enrich the C20-22 LC PUFAs.
Triacylglycerol acyl hydrolases specifically hydrolyse
carboxyl esters of triglycerides into free fatty acids
and partial acylglycerols. The unique characteristics
of this group of enzymes such as positional and
stereospecificity were utilized to selectively
concentrate targeted fatty acids in triglycerides that
can be readily absorbed into plasma triglycerides.
PUFA enrichment by different physicochemical
procedures
The crude sardine oil was clarified by a sequential
process of degumming, decolorization, and
Figure 2. Biosynthetic pathways of the long chain polyunsaturated fatty acids (LC-PUFA)
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deodorization, and was found to contain LC-PUFAs,
particularly 20:5 n-3 or EPA (17.80 ± 1.57%) of total
fatty acids, TFA) and 22:6 n-3 or DHA (7.67 ± 1.50%
of TFA) along with other n-3 and n-6 PUFAs like
Linolenic acid (LA or 18:3 n-3; 4.47 ± 0.84% TFA),
Linoleic acid (18:2 n-6; 0.71 ± 0.23% TFA), and
Docosapentaenoic acid (DPA or 22:5 n-3; 1.14 ± 0.08%
TFA) (Fig. 3). The n-6 fatty acids have a minor share
of the total fatty acid content of sardine oil (0.81%
TFA). The PUFAs containing C18– C22 acyl chain length
contributed a major share of the total fatty acids of
the sardine oil (>30% TFA). Among the saturated fatty
acids (SFAs), 14:0 was found to be predominant (7.04
± 0.22% TFA), while 16:1 n-7 contributed the major
share (31.56 ± 2.59% TFA) among the
monounsaturated fatty acids (MUFAs). When fatty
acids are required in free form for further analyses,
lipids were hydrolyzed in alkaline medium for
extracting the unsaponifiable material. Sardine oil
was saponified with NaOH/Na2EDTA to yield free fatty
acids. Na2EDTA appeared to form complex with traces
of metal ions (Cu, Fe), which catalyze oxidation of
unsaturated fatty acids during saponification, and
subsequently removed by extraction with water thus
hindering the interferences of metal ions during the
course of further purification process. Relatively large
volumes of n-hexane were added to the aliquot of
the salt of fatty acid mixtures for better phase
separation, thus removing the unsaponificable
materials. Among saturated fatty acids (SFAs), 14:0
was found to be predominant (7.04% TFA), while
16:1n-7 contributed the major share among all
individual fatty acids in the crude sardine oil (>31%
TFA). EPA and DHA were found to be the major n-3
PUFAs contributing to 17.8% and 7.67% of TFA,
respectively. The n-6 fatty acids have minor share in
the total fatty acid content of sardine oil. Solvent
extraction resulted in marginal increase of
unsaturation (0.85%) in the fatty acid profile.  The
PUFA exhibited an increase of 6.49%, while MUFA and
SFA reduced by 2.96% and 6.91% respectively. The
n-3 fatty acids exhibited an increase of 5.73% in the
solvent extract of fatty acids.
The free fatty acids derived from sardine oil were
subjected to amide fractionation using methanol as
solvent at three different temperatures and urea-
fatty acid ratios to obtain PUFAs of high purity. The
interfering SFAs and most of the MUFAs were removed
in the form of amide inclusion compound. Further,
as oxidized products do not form amide adducts, the
peroxidation of n-3 PUFAs could be avoided during
the extraction of free acids from fish oil triglycerides.
Amide fractionation resulted in total reduction of
SFAs (>95%) (14:0, 16:0, and 17:0), moderate
reduction of MUFAs (>65%). The U/FA ratio of 4:1
(w/w) was found to be optimal for getting high-purity
EPA (47.8%) while that at 3:1 (at 20 C) yielded higher
content of DHA (>20 %) when crystallized at 20C.
Based on these results, DHA obtained from sardine
oil at 2°C temperature of amide-crystallization by
using a U/FA ratio of 3:1 was selected for subsequent
purification of C22 fatty acid DHA. It is likely that at
the lower temperature (20C), the reaction kinetics
to form amide-inclusion complex with SFAs and
MUFAs was relatively lower resulting in higher DHA
in the extract.
Fig. 3. Fatty acid composition of crude and solvent
extracted sardine oil, and PUFA concentrate
obtained by the amide fractionation (U/FA:
amide/fatty acid ratio)
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Change in fatty acid composition as a function of
microbial triacylglycerol acyl hydrolase-catalyzed
hydrolysis of fatty acids from sardine oil
The free fatty acids were esterified by using a
mixture of ethyl alcohol and 0.1 (N) H2SO4  resulting
in the ethyl ester of the fatty acids. An extracellular
triacylglycerol acyl hydrolase derived from Bacillus
subtilis isolated from marine macroalga, Turbinaria
conoides, was used to prepare C22 n-3 polyunsaturated
fatty acid concentrates from the ester fraction. The
enzyme was purified 132-fold with specific activity
of 386 triacylglycerol acyl hydrolase units/mg. The
urea fractionated fatty acyl esters were hydrolyzed
with enzyme purified from the bacterium Bacillus
subtilis and the TFA content of fatty acyl esters after
lipase hydrolysis were analyzed. SFA levels showed a
reduction to 0.05% after 3 hours (h) of hydrolysis.
The decrease in the content of SFAs and MUFAs in
the fatty acyl ester mixture with the progress of
hydrolysis suggested that SFAs and MUFAs were more
easily hydrolyzed by the lipase than those in esterified
fatty acids that contain DHA, resulting in the
enrichment of the latter in the ester fraction.
The variations of PUFA content of sardine oil
triglycerides as a function of time during the microbial
triacylglycerol acyl hydrolase-catalyzed hydrolysis are
illustrated (Fig. 4). The total DHA of fatty acyl ester
fraction increased with time up to 3 h of enzyme-
catalyzed hydrolysis (35.27% TFA), beyond which it
slowly decreased (9.81% TFA after 9 h). The purified
triacylglycerol acyl hydrolase was able to enrich DHA
with 35.27% 22:6 n-3 after 3 h of hydrolysis. The
results also suggested that the esteritic bonds of C22
acyl chain lengthened n-3 PUFAs are resistant to
hydrolysis by the lipase. However, after prolonged
hydrolysis (>9 h), when only a few target fatty acid
ester bonds (n-6 fatty acyl ester bonds and esters
other than C22 n-3 fatty acids) were available in the
enzyme hydrolysate that were susceptible to hydrolysis
by the bacterial hydrolase, the microbial
triacylglycerol acyl hydrolase could cleave bonds highly
resistant to hydrolysis, i.e., DHA. It can therefore
be concluded that it is possible to separate and
concentrate C22 PUFAs with n-3 double bonds like DHA
using lipase from seaweed associated bacteria like
Bacillus subtilis.
Separation of phospholipid fraction from the seer
fish roe and preparation of DHA rich oil emulsion was
also done.The total lipids of seer fish roe were
separated into different lipid classes by silicic acid
column chromatography. The lipid fractions were
qualitatively analyzed by Thin Layer Chromatography
(TLC) for identifying triglycerides, glycolipids and
phospholipid components. Fatty acid methyl esters
(FAMEs) of the total lipid and the individual lipid
classes were prepared by transesterification process.
The DHA enriched fatty acid concentrate was enriched
through biochemical and microbiological procedures
to formulate enrichment emulsions which contained
roughly, 90% DHA enriched fatty acid concentrate and
10% phospholipids fraction extracted from seer  fish
roe. The aggregate content of DHA in fish roe
phospholipidic fraction was recorded as 24.3% DHA
along with 5.2% EPA. The polyunsaturated fatty acid
concentrate of the fish body oil after adding fish roe
was found to contain greater than 35% DHA with
significantly lesser content of saturated fatty acids
(0.22%) and monounsaturated fatty acids (~7% of
total fatty acids).
Fig. 4. Fatty acid composition of urea concentrated
fatty acids, triacylglycerol acyl hydrolase-
catalyzed fatty acid concentrate, seer fish roe,
and DHA rich concentrate
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Fig. 5. Polyoxyethylene derivative of sorbitan
monolaurate (or Polysorbate 20)
Use of emulsifiers to increase the stability of
enriched PUFA emulsion
 An emulsion is a mixture of two or more liquids
that are normally immiscible and  an emulsifier is a
substance that stabilizes an emulsion by increasing
its kinetic stability. Emulsion should be used when
both the dispersed and the continuous phase are
liquids. An experiment was conducted to understand
the effect of emulsifier to stabilize the DHA
concentrate. The emulsifier used was Tween 20 (or
Polysorbate 20), which was able to contain the
stability of the preparation for an extended time
period (Figs. 5 & 6). Longer chain TAGs such as
polysorbate 20 are more hydrophobic and therefore
have higher oil/water interfacial tension than shorter
chain ones. The stability of the PUFA concentrate (as
such without Polysorbate 20) decreased after 15
minutes whereas the same appended with Polysorbate
20 was able to maintain the stability for an extended
period of time due to increased kinetics (increased
Brownian movement)
Conclusions
A fatty oil from the livers of various fishes (as
cod, halibut or sharks) used chiefly as a source of
fatty acids, vitamin A and also of vitamin D is called
fish liver oil. Fish oil is short for “fish body oil” and
not the same thing as “cod liver oil” available in the
market. Cod liver oil contains greater concentrations
of vitamin A. Taking cod liver oil in the same amounts
that are recommended for fish oil can be toxic, and
even more so in people who have chronic renal failure
(because vitamin A can build up to toxic levels). The
C20-22 n-3 polyunsaturated fatty acid concentrate
prepared from the inexpensively available marine
sources, such as sardine oil can be a potential
substitute of the imported PUFA supplements as
functional food product.The PUFA enriched
formulation (Fig. 7) from low value “fish body oils”
will also overcome the risks associated with
hypervitaminosis (A, D) and exposure to
environmental toxins (mercury, PCBs, dioxins etc.)
associated with “liver oils” available in market. The
indigenous n-3 polyunsaturatated fatty acids
emulsion developed from the locally available low-
value fish may also serve as a cheaper alternative to
the imported fatty acid emulsions used in fish larval
nutrition during mariculture operations.
Fig. 6. Photomicrograph of a water-in-oil emulsion by
using Tween 20
Fig. 7. Polyunsaturated fatty acid concentrate
prepared from sardine oil. (A) Crude sardine
oil (B) PUFA concentrate
(A) (B)
